Brief: Aeon Biopharma And Priveterra Acquisition Corp Announce Additional Capital Commitment From Existing Investors For At Least $20 Mln
10/01/2023 12:32
Jan 10 (Reuters) - Priveterra Acquisition Corp PMGM.O :
* AEON BIOPHARMA AND PRIVETERRA ACQUISITION CORP. ANNOUNCE
ADDITIONAL CAPITAL COMMITMENT FROM EXISTING INVESTORS FOR AT
LEAST $20 MILLION
Source text for Eikon: ID:nGNX79ftg4
Further company coverage: PMGM.O
((reuters.briefs@thomsonreuters.com;))
Recent news on Aeon Biopharma
See all newsBrief: Aeon Biopharma Reports bpd Type 2A Meeting With FDA And Shareholder Approval Of The November Transactions
Brief: Aeon Biopharma Announces Execution Of Exchange Agreement With Daewoong
Brief: Aeon Biopharma Announces First Closing Of Pipe Investment And Provides Update On FDA Type 2A Meeting Scheduling
Brief: Aeon Biopharma Announces FDA bpd Type 2A Meeting For Abp-450 On November 19
Brief: Aeon Biopharma Announces CEO Transition